NDC 0409-2222-01 - Heparin Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-2222
- Requested NDC
- 0409-2222-01
- Package NDCs from labels
- 0409-2222-01, 0409-2222-12
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-05-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Heparin Sodium - Hospira, Inc. | Hospira, Inc. | 2026-05-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-2222-01 | Heparin Sodium | 1000 mL in 1 BAG | INJECTION, SOLUTION | 1000 | 34 | |
| 0409-2222-12 | Heparin Sodium | 1 in 1 POUCH | INJECTION, SOLUTION | 1 | 34 | |
| 0409-2222-12 | Heparin Sodium | 12 in 1 CASE | INJECTION, SOLUTION | 12 | 34 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-2222-01 | ML - Milliliter | 0409-2222 | 9c1e0a7c-59c7-4087-bcfd-d5ac72d189b8 | 1 | 2023-03-13 |
| 0409-2222-12 | ML - Milliliter | 0409-2222 | 2ddfe4c7-4c9a-494f-9ca5-66013a6d2838 | 1 | 2023-03-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HEPARIN SODIUM | ACTIVE INGREDIENT | ZZ45AB24CA | HEPARIN SODIUM INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| HEPARIN | ACTIVE MOIETY | T2410KM04A | HEPARIN SODIUM INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | HEPARIN SODIUM INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | HEPARIN SODIUM INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INACTIVE INGREDIENT | 70WT22SF4B | HEPARIN SODIUM INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | HEPARIN SODIUM INJECTION, SOLUTION [HOSPIRA, INC.] | 15 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jacksons Cell Salts NAT MUR 6X 9 | NATRUM MURIATICUM | Zettl Health Inc. | 3cbe47fc-db38-e6e9-e063-6294a90a3f1c | 2025-08-19 | Warnings | 451W47IQ8X |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | 9207cef5-4cec-41e7-a351-29ba726feb44 | 2025-08-15 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | 07438e10-1589-4683-9f26-e5494d076cf0 | 2025-08-15 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Hikma Pharmaceuticals USA Inc. | 7014808d-cec9-4b2c-8eb5-940493e356ab | 2025-08-13 | Warnings, Adverse reactions | ZZ45AB24CA |
| QUALITY CHOICE SALINE | SODIUM CHLORIDE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f51491d8-12ad-4b1b-a171-c621bfdcc341 | 2025-08-12 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | e0466bb3-6c26-4044-b051-69f48b67f632 | 2025-08-07 | Adverse reactions | 451W47IQ8X |
| Heparin Sodium in Sodium Chloride | HEPARIN SODIUM IN SODIUM CHLORIDE | B. Braun Medical Inc. | a3041c04-0ea8-4d36-81ce-c5091c906316 | 2025-08-06 | Warnings, Adverse reactions | 1658692 1658690 ZZ45AB24CA |
| Schuessler Tissue Salts Nat Mur Fluid Balance 9 | NATRUM MURIATICUM | Martin & Pleasance Pty Ltd | 08da6353-9625-4e8f-8575-a2b49f5d2ac6 | 2025-08-04 | Warnings | 451W47IQ8X |
| Gout Relief 3310-S | CELERY SEED, MEDICAGO SATIVA WHOLE,CHICORY ROOT | Bispit Canada Ltd. | 3afaa7d9-3de3-52d9-e063-6294a90a54ec | 2025-08-02 | Warnings | 451W47IQ8X |
| Heparin Sodium in Sodium Chloride | HEPARIN SODIUM IN SODIUM CHLORIDE | B. Braun Medical Inc. | 8b030692-fc66-4c53-85aa-6f865e635618 | 2025-07-31 | Warnings, Adverse reactions | ZZ45AB24CA |
| QUALITY CHOICE SALINE | PLUS SOOTHING ALOE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 4ae4e88a-aaa5-4195-bedc-622fd5cd9394 | 2025-07-30 | Warnings | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | 9e72418a-376e-4637-99ad-d13c904a7986 | 2025-07-30 | Warnings, Adverse reactions | 451W47IQ8X |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 985a3341-0fe0-1dd6-e053-2a95a90ad2c5 | 2025-07-25 | Warnings | 451W47IQ8X 70WT22SF4B |
| Dairy-Grain-Nightshade | IRIS VERS., SOLIDAGO, ANTIMON. CRUD., ARG. NIT., ARSENICUM ALB., AVENA, BAPTISIA, BELLADONNA, BRYONIA, CAPSICUM, CARDUUS BEN., CINCHONA, DULCAMARA, FAGOPYRUM, GELSEMIUM, HYOSCYAMUS, IPECAC., LAC VAC., LACHESIS, LYCOPODIUM, NAT. MUR., PHOS., PODOPH. PELT., PULSATILLA, RHUS TOX., SAC. LAC., SECALE, SEPIA, STRAMONIUM, TABACUM, TRITICUM, USTILAGO MAIDIS, VERBASCUM, LYCOPERSICUM, SOLANUM NIG., SOLANUM TUB., STIGMATA, TORULA CEREVISIAE. | Newton Laboratories, Inc. | 99fcbd61-ecc8-cf9d-e053-2995a90aebeb | 2025-07-25 | Warnings | 451W47IQ8X |
| Bedwetting | ECHINACEA, HYDRASTIS CANADENSIS, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS, BELLADONNA, CANTHARIS, CAUSTICUM, EQUISETUM HYEMALE, FERRUM METALLICUM, GELSEMIUM SEMPERVIRENS, HUMULUS LUPULUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PLANTAGO MAJOR, PULSATILLA, RHUS AROMATICA, SABAL SERRULATA, THYROIDINUM, VERBASCUM THAPSUS | Newton Laboratories, Inc. | 9d5f51d0-01e9-271c-e053-2995a90a63bc | 2025-07-24 | Warnings | 451W47IQ8X |
| Bedwetting | ECHINACEA, HYDRASTIS CANADENSIS, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS, BELLADONNA, CANTHARIS, CAUSTICUM, EQUISETUM HYEMALE, FERRUM METALLICUM, GELSEMIUM SEMPERVIRENS, HUMULUS LUPULUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PLANTAGO MAJOR, PULSATILLA, RHUS AROMATICA, SABAL SERRULATA, THYROIDINUM, VERBASCUM THAPSUS | Newton Laboratories, Inc. | 9d6058a0-69dd-66d0-e053-2a95a90a58f8 | 2025-07-24 | Warnings | 451W47IQ8X |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | 451W47IQ8X 70WT22SF4B |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1a9ef9-9a54-5f94-e053-2a91aa0ab477 | 2025-07-24 | Warnings | 451W47IQ8X 70WT22SF4B |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2025-07-23 | Warnings, Adverse reactions | 451W47IQ8X |
| BACTERIOSTATIC SODIUM CHLORIDE | SODIUM CHLORIDE | ProPharma Distribution | 3868864f-4f46-d2a1-e063-6394a90a65d5 | 2025-07-18 | Boxed warning, Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.